Author:
Smieszek Sandra P.,Kaden Alyssa R.,Johnson Caroline E.,Brzezynski Jennifer L.,Xiao Changfu,Polymeropoulos Christos M.,Birznieks Gunther,Emsellem Helene A.,Polymeropoulos Mihael H.
Abstract
We present a case of an adult female diagnosed with Delayed Sleep-Wake Phase Disorder (DSWPD) and Optic Nerve Hypoplasia (ONH), with a confirmed delayed Dim Light Melatonin Onset (DLMO), who reports the inability to fall asleep at their desired bedtime and obtain adequate sleep nightly, despite the ability to have a full night’s sleep when not required to be up at a specific time for societal requirements. The participant was enrolled in an 11-month Open-Label Extension (OLE) following the randomized portion of a clinical study and was successfully treated with tasimelteon. DSWPD symptoms were resolved, and their previously delayed sleep-wake cycle was advanced.Clinical trial registrationhttps://clinicaltrials.gov/ct2/show/NCT04652882, identifier NCT04652882.